Sightseeing on the Chicago River City of Chicago / Javet M. Kimble

The sixth annual ASH State-of-the-Art Symposium (SAS) took place at the Palmer House Hilton in Chicago, IL, on September 12-13. With a sell-out crowd, 13 stimulating educational sessions led by expert speakers, and 11 commercial supporters and exhibitors, this meeting can truly be called a success.

If you missed the 2008 SAS, you can purchase both the Program Book and DVD of the meeting through the ASH Store. The Program Book contains the printed session slides from each presentation given. The DVD features audio synchronized to the slides of each of the presentations from this event. These educational products will be available for sale in October.

Sessions included:

Stem Cell Biology Unveiled
Hal E. Broxmeyer, PhD, Indiana University School of Medicine

Changes in the World Health Organization (WHO) Classification of Myeloid Malignancies
James W. Vardiman, MD, University of Chicago

Complement, Immunity, and Stem Cell Hypoplasia
Neal S. Young, MD, National Institutes of Health

The New Paradigm in MDS Management
Alan F. List, MD, H. Lee Moffitt Cancer Center

MPDs Come of Age
Ayalew Tefferi, MD, Mayo Clinic

CML after Imatinib
Jorge Cortes, MD, M. D. Anderson Cancer Center

Managing CLL by Prognostic Risk
Mark A. Weiss, MD, Memorial Sloan-Kettering Cancer Center

Discriminating Outcome and Treatment Strategies for AML
Martin S. Tallman, MD, Northwestern University

Myeloma Stem Cell Transplant: If, When, and Why?
Sagar Lonial, MD, Winship Cancer Institute

The New Standards for Myeloma Medical Management
Irene Ghobrial, MD, Dana-Farber Cancer Institute

Update on Treatment Options for Follicular Lymphoma
Stephanie A. Gregory, MD, Rush University Medical Center

Novel Approaches for the Treatment of Mantle-Cell Lymphoma
Brad Kahl, MD, University of Wisconsin

Hodgkin Lymphoma: Streamlining Therapy Based on Stage and Risk Factors
Joseph M. Connors, MD, British Columbia Cancer Agency

The American Society of Hematology would like to thank the following SAS commercial supporters and exhibitors: